Waiting For Inspections, Biocon Seeks US FDA Stance On Mutual Recognition Agreement Route

 
• By Anju Ghangurde
Indian Firms Face Limited Visibility In Inspection Schedules • Source: Nielsen Hobbs

More from Manufacturing

More from Compliance